SalaryGuide
SalariesCompaniesJobs
AboutPricingBlog
For Employers
CompaniesGondolaBioSalaries
GondolaBio logo

GondolaBio

Brand

  • Overview
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links
  • Insights
  • Jobs

Loading company data...

Loading jobs...

SalaryGuide

The career growth platform that helps marketers earn what they're worth. Transparent salaries, jobs, company intel, and AI tools built for marketers.

For Jobseekers

  • Browse Jobs
  • Marketing Salaries
  • Companies
  • Add Your Salary
  • Pricing

For Employers

  • Employer portal
  • Salary Reports
  • Employer Pricing
  • About for Employers

Company

  • About Us
  • Methodology
  • Editorial Policy
  • Josh Peacock
  • Blog
  • Careers
  • Contact Us
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Refund Policy

Popular salaries

All salaries →
  • Marketing Manager
  • Marketing Director
  • Product Marketing Manager
  • SEO Manager
  • Social Media Manager
  • Brand Manager
  • Growth Marketing Manager
  • Content Strategist
  • Demand Generation Manager
  • Marketing Coordinator

Popular job searches

All marketing jobs →
  • Product Marketing jobs
  • Content Marketing jobs
  • Social Media jobs
  • Brand Marketing jobs
  • Growth Marketing jobs
  • SEO jobs
  • Paid Media jobs
  • Demand Generation jobs
  • Communications jobs
  • Email Marketing jobs

© 2026 SalaryGuide. All rights reserved.

Team and salary summaries are not available for this company yet.

Company overview

Open marketing roles

1

  • Communications
Hiring pace

Low

1 marketing job posted in the last 90 days

Work arrangement

100% on-site

Based on 1 open role

Founded in 2024
Palo Alto, California, USA
68 employees
gondolabio.com

Salaries

Help build salary transparency at GondolaBio

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

1 open now

Headcount trend

Company growth over the last 12 months

Headcount +163% year over year

Funding

Total funding

$300M

Last raise

$300M

Series Unknown, 2 years ago

Funding history

Aug 2024

Venture Round GondolaBio · $300M

Audience

Monthly website visitors
4.3K
Month over month+48.7%
Quarter over quarter-40.1%
Top sourceDirect (47.8%)
Ad budget per month$0.0
Average search rank32.6
Traffic source mix
Direct
47.8%
Search
40.5%
Social
5.6%
Referral
4.4%
Paid referral
1.5%

LinkedIn followers

Follower count and growth

Total followers

4.1K

12-mo growth

+631.9%

Monthly growth

+41.6%

News

GondolaBio Receives U.S. FDA Orphan Drug and Fast Track Designations for PORT-77 for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
Oct 21, 2025 • Yahoo Finance
BridgeBio’s GondolaBio bet skirts industry’s focus on small pipelines
Oct 3, 2025 • Endpoints News
N-Lorem, Gondolabio to advance ASO treatment for rare diseases
Jan 8, 2025 • AADC News

Links

gondolabio.comLinkedInCrunchbase

Loading insights...

Open positions1 open marketing positions

GondolaBio logo

Sr. Director, Portfolio Positioning & Communications

GondolaBio

Palo Alto, CA (On-site)

$316K/yr - $347K/yrIn-houseFull-timeSenior level8+ years exp.
12 days ago

Similar roles at other companies

AE2S (Advanced Engineering and Environmental Services, LLC) logo

Communications Strategist

AE2S (Advanced Engineering and Environmental Services, LLC)

Maple Grove, MN (On-site)

$79K/yr - $110K/yrIn-houseFull-timeSenior level8+ years exp.
1 day ago

Senior HPC Communications Specialist

Lawrence Berkeley National Laboratory

Berkeley, CA (Hybrid)

$135K/yr - $165K/yrIn-houseFull-timeSenior level8+ years exp.
1 day ago
Berkeley Lab logo

Senior HPC Communications Specialist

Berkeley Lab

Berkeley, CA (Hybrid)

$135K/yr - $165K/yrIn-houseFull-timeSenior level8+ years exp.
1 day ago
Ionis Pharmaceuticals, Inc. logo

Associate Director, Scientific Communications

Ionis Pharmaceuticals, Inc.

Carlsbad, CA (Remote)

$175K/yr - $210K/yrIn-houseFull-timeSenior level5+ years exp.
1 day ago

GondolaBio insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded
2024
Headquarters
Palo Alto, California
Employees
11-50
163% growth last 12mo
Marketing team
—
2 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result
Low risk
Late-stage · Growing 163% last 12 months · Young company
Trend
2024-01-29 -> 2026-02-09
Headcount (12 months)
+163%
Last funding round
19 months ago
Negative news (120 days)
0
Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors
4.3K
Month over month+48.7%
Quarter over quarter-40.1%
Top sourceDirect (47.8%)
Traffic source mix
Direct
47.8%
Search
40.5%
Social
5.6%
Referral
4.4%
Paid referral
1.5%

Competitors and search

Shows competitors and key search metrics in one view.

Main result
0 competitor sites
Search traffic: 26 organic clicks / 0 paid clicks
Organic competitors
0
Paid competitors
0
Keyword change
+6
Ad budget per month
$0.0
Average search rank
32.6

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

4.1K

12-mo growth

+631.9%

Monthly growth

+41.6%

Job openings

Shows open jobs, growth, and role changes.

Main result
2 open jobs
Open jobs trend: —
Trend
2025-04-01 -> 2026-02-01
Open jobs growth
—
Biggest role change
—
Latest open role
Vice President, Clinical Development

Marketing team size

Shows saved marketing team size.

—
2 saved marketing people

Funding

Shows saved funding data.

Total funding
$300M
Last raise
Series Unknown
2 years ago
Funding details
Amount raised
$300M
Last round
Series Unknown
Last fundraise
2 years ago

News

Shows saved company news.

GondolaBio Receives U.S. FDA Orphan Drug and Fast Track Designations for PORT-77 for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
Oct 21, 2025 • Yahoo Finance
BridgeBio’s GondolaBio bet skirts industry’s focus on small pipelines
Oct 3, 2025 • Endpoints News
N-Lorem, Gondolabio to advance ASO treatment for rare diseases
Jan 8, 2025 • AADC News